Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
504148
Reference Type
Journal Article
Title
Restless legs syndrome induced by citalopram: a psychiatric emergency?
Author(s)
Nader, P; Coralie, L; Baleydier, B; Andrei, C; Susanne, M; Damsa, C
Year
2007
Is Peer Reviewed?
Yes
Journal
General Hospital Psychiatry
ISSN:
0163-8343
Volume
29
Issue
1
Page Numbers
72-74
Language
English
DOI
10.1016/j.genhosppsych.2006.10.006
Abstract
Objective: The objective of this case report is to create awareness on restless legs syndrome (RLS) among clinicians working in emergency units. Method: We describe a case reporting important aggravation of RLS associated with citalopram, 60 mg/day, in a 48-year-old woman who was sent to the emergency unit by her general practitioner. Citalopram was replaced by bupropion, 150 mg/day, and sertraline, 50 mg/day. Results: Three days later, symptoms of RLS started to diminish and, after 3 weeks, clinical symptoms had disappeared entirely. On 6-month follow-up, the patient did not manifest clinically significant RLS. Ignoring RLS could lead to a worsening of symptoms and could increase the risk for iatrogenic conditions. The prevalence of RLS in the general population is 3-9%; nevertheless, this syndrome is frequently underdiagnosed. Conclusion: This case report suggests that RLS could be considered as a possible "dopamine-dependent side effect" of selective serotonin reuptake inhibitors (SSRIs). Bupropion could potentially "correct" dopaminergic dysfunction in RLS, and sertraline appears to be the SSRI that provides the least risk of RLS by blocking dopamine reuptake. (c) 2007 Elsevier Inc. All rights reserved.
Keywords
restless legs syndrome; citalopram; bupropion; sertraline; antidepressants; SSRI; side effects; paroxetine
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity